BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer
Release time:
2024-08-01
2024 August 1st – BrosMed Medical is pleased to announce the appointment of Scott J. Addonizio as its Chief Operating Officer (COO), effective immediately. Mr. Scott J. Addonizio brings a wealth of experience and expertise to BrosMed, with a distinguished career spanning almost 30 years in the medical device industry. Prior to joining BrosMed, Mr. Addonizio served as SVP at Cordis and COO at MedAlliance Swiss Medical Technology.
2024 August 1st – BrosMed Medical is pleased to announce the appointment of Scott J. Addonizio as its Chief Operating Officer (COO), effective immediately.
Mr. Scott J. Addonizio brings a wealth of experience and expertise to BrosMed, with a distinguished career spanning almost 30 years in the medical device industry. Prior to joining BrosMed, Mr. Addonizio served as SVP at Cordis and COO at MedAlliance Swiss Medical Technology. He was instrumental in raising investment capital for the continued funding for MedAlliance, scaling up operations to provide for double digit growth and overseeing global operations prior to being acquired by Cordis in October of 2023. In addition, Mr. Addonizio served as a board director of OrbusNeich Medical and was the COO responsible for global operations including sales and marketing which achieved global revenue of approximately 100 Million prior to his transition back to the United States in 2019. Mr. Addonizio currently holds key positions at multiple corporations, including serving as a Board of Directors for Simpson Intervention and a General Partner with Cultivation Capital.
“I’m very fortunate to be given the opportunity to join BrosMed and reconnect with my old friend Mr. Benny Lee. BrosMed has grown to be a considerable player in the global vascular marketplace and I’m excited to further expand its global footprint through continued technology and product innovation,” comments Mr. Addonizio. “Having spent almost one-third of my life outside the US, 15 of those years in China, and the last 5 years reconnecting with my roots in the US, the timing is perfect for such an optimal collaboration.”
Mr. Benny Lee, Chairman & CEO of BrosMed, said, “Scott and I have known each other for 23 years, having worked closely together for 7 years. Scott is a responsible, motivated, and highly dedicated individual. I have learned a lot from him. Scott and I have a love for basketball for which we often led our teams to participate in competitive games, enjoying lessons of cooperation and competition during clutch matches.” Benny added, “Today I am very excited to announce that we have the honor to invite Scott to join our growing family of BrosMed Medical. We have an incredible history together and after 12 years the two of us can once again join forces. BrosMed Medical is a focused team with creative and ambitious goals, and we believe that the addition of Scott as global COO will further enhance BrosMed’s ability to serve global customers and patients, while also creating greater value for our distinguished partners.”
About BrosMed Medical
Specializing in the research, development, manufacturing, and global sales of interventional technologies and products for complex vascular diseases, BrosMed is the industry-leading multinational group in the field of intravascular interventional medical devices. We have over 20 product series and more than 500 product registration certificates worldwide. Our products cover various fields including cardiovascular intervention, peripheral intervention, vascular access, neurovascular intervention, and interventional accessories, and are marketed in over 100 countries and regions globally.
BrosMed Medical adheres to the mission of “Technology Embraces Life,” actively practices a globalized integration of medical and engineering, and promotes an open innovation model of integrating industry, universities, and scientific research institutions. We are dedicated to continuously providing safe, effective, high-quality, and innovative intravascular interventional solutions for global experts and patients.
Join with Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
Webinar Invitation | Mastering PTA: From Peripheral Arteries to AV Fistulas
Mark your calendar: Tuesday, June 24 🕒 19:00-20:30 UTC+8 (BJT) | 20:00-21:30 UTC+9 (KST)
2025-06-18
Join Us at AngioPicture 2025 for the AVF Seminar!
BrosMed Medical cordially invites you to attend our AVF Seminar at AngioPicture 2025, held on May 30th at Pullman Sochi Centre, Sochi, Russia.
2025-05-20
BrosMed Announced CE MDR Approval of New Generation Conger™ Plus Hydrophilic Guidewires
Designed for superior crossability and maneuverability in peripheral interventions, Conger Plus now offers 116 models with expanded sizes (OD 0.018'' to 0.038'') and lengths (up to 300cm).
2025-04-28
BrosMed to Showcase Innovative Solutions for CHIP PCI at EuroPCR 2025
Date: May 20-23, 2025 Venue: Palais des Congrès de Paris, Paris, France Booth No.: M20
2025-04-15
"Experience TCTAP 2025: Join Us with BrosMed!"
Save the Date April 23–26, 2025 and visit us at Booth #D41 to explore more highlights!
2025-04-08